Smith & Nephew PLC ADR (SNN): Price and Financial Metrics
SNN Price/Volume Stats
Current price | $26.67 | 52-week high | $33.08 |
Prev. close | $27.01 | 52-week low | $21.52 |
Day low | $26.67 | Volume | 391,700 |
Day high | $26.92 | Avg. volume | 977,943 |
50-day MA | $27.70 | Dividend yield | 2.02% |
200-day MA | $27.23 | Market Cap | 11.66B |
SNN Stock Price Chart Interactive Chart >
SNN POWR Grades
- Value is the dimension where SNN ranks best; there it ranks ahead of 85.83% of US stocks.
- SNN's strongest trending metric is Quality; it's been moving down over the last 26 weeks.
- SNN ranks lowest in Momentum; there it ranks in the 24th percentile.
SNN Stock Summary
- With a market capitalization of $11,598,139,266, SMITH & NEPHEW PLC has a greater market value than 84.43% of US stocks.
- SNN's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 2,288.5 -- higher than 98.59% of US-listed equities with positive expected earnings growth.
- With a price/earnings ratio of 52.01, SMITH & NEPHEW PLC P/E ratio is greater than that of about 86.5% of stocks in our set with positive earnings.
- Stocks with similar financial metrics, market capitalization, and price volatility to SMITH & NEPHEW PLC are JHX, KAI, CPB, BCPC, and STRA.
- Visit SNN's SEC page to see the company's official filings. To visit the company's web site, go to www.smith-nephew.com.
SNN Valuation Summary
- SNN's price/earnings ratio is 53.7; this is 84.22% higher than that of the median Healthcare stock.
- Over the past 217 months, SNN's price/sales ratio has gone down 3.7.
Below are key valuation metrics over time for SNN.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
SNN | 2023-12-29 | 2.3 | 2.3 | 53.7 | 47.1 |
SNN | 2023-12-28 | 2.3 | 2.3 | 53.7 | 47.1 |
SNN | 2023-12-27 | 2.3 | 2.3 | 53.9 | 47.2 |
SNN | 2023-12-26 | 2.3 | 2.3 | 54.0 | 47.3 |
SNN | 2023-12-22 | 2.3 | 2.3 | 53.7 | 47.1 |
SNN | 2023-12-21 | 2.3 | 2.3 | 53.2 | 46.7 |
SNN Growth Metrics
- Its year over year net cashflow from operations growth rate is now at 7.82%.
- Its 5 year net cashflow from operations growth rate is now at 32.37%.
- The year over year net income to common stockholders growth rate now stands at 16.96%.
The table below shows SNN's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 5,215 | 581 | 223 |
2022-06-30 | 5,212 | 1,048 | 524 |
2021-12-31 | 5,212 | 1,048 | 524 |
2021-12-31 | 5,212 | 1,048 | 524 |
2021-06-30 | 4,560.001 | 972.0003 | 448.0001 |
2020-12-31 | 4,560 | 972 | 448 |
SNN's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SNN has a Quality Grade of B, ranking ahead of 77.5% of graded US stocks.
- SNN's asset turnover comes in at 0.445 -- ranking 108th of 186 Medical Equipment stocks.
- HOLX, TTOO, and BIOL are the stocks whose asset turnover ratios are most correlated with SNN.
The table below shows SNN's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-07-03 | 0.445 | 0.694 | 0.050 |
2020-12-31 | 0.449 | 0.694 | 0.051 |
2020-12-31 | 0.449 | 0.694 | 0.051 |
2020-06-27 | 0.556 | 0.740 | 0.146 |
2019-12-31 | 0.592 | 0.740 | 0.174 |
2019-12-31 | 0.592 | 0.740 | 0.174 |
Smith & Nephew PLC ADR (SNN) Company Bio
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. (Source:Wikipedia)
Latest SNN News From Around the Web
Below are the latest news stories about SMITH & NEPHEW PLC that investors may wish to consider to help them evaluate SNN as an investment opportunity.
Is Smith & Nephew plc (LON:SN.) Trading At A 40% Discount?Key Insights Smith & Nephew's estimated fair value is UK£17.05 based on 2 Stage Free Cash Flow to Equity Smith... |
Smith & Nephew (SNN) New Buyout Expands Sports Medicine SuiteSmith & Nephew (SNN) will pay an initial cash consideration of $180 million at closure, with an additional $150 million based on financial performance to acquire CartiHeal. |
Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implantBioventus’ protracted buyout bid ultimately fell apart and opened the door to Smith & Nephew. |
After losing 1.8% in the past year, Smith & Nephew plc (LON:SN.) institutional owners must be relieved by the recent gainKey Insights Significantly high institutional ownership implies Smith & Nephew's stock price is sensitive to their... |
Shareholders in Smith & Nephew (LON:SN.) are in the red if they invested three years agoAs an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand... |
SNN Price Returns
1-mo | -4.95% |
3-mo | 0.26% |
6-mo | 6.16% |
1-year | -3.74% |
3-year | -24.20% |
5-year | -26.03% |
YTD | -2.24% |
2023 | 4.35% |
2022 | -20.26% |
2021 | -16.26% |
2020 | -10.45% |
2019 | 30.78% |
SNN Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching SNN
Here are a few links from around the web to help you further your research on Smith & Nephew Plc's stock as an investment opportunity:Smith & Nephew Plc (SNN) Stock Price | Nasdaq
Smith & Nephew Plc (SNN) Stock Quote, History and News - Yahoo Finance
Smith & Nephew Plc (SNN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...